The bone metabolism treatments market generated pharmaceutical revenues of over $12 bn worldwide in 2009. The incidence and prevalence of bone metabolism disorders are on the rise worldwide, in line with an ageing population and improvements in diagnosis. The increasing number of older people offers significant commercial and therapeutic opportunities. The number of osteoporosis and other bone metabolism patients may exceed 400 million by 2020, reports suggest. Governments and other healthcare providers are investing in health education, diagnosis and treatments for those chronic, debilitating - but controllable - disorders, as our new report discusses.

As Osteoporosis & Bone Metabolism Disorders: World Market 2010-2025 shows, this field is important therapeutically and commercially. Which segments of the bone metabolism disorders market will grow fastest in years to come? How will the osteoporosis market cope with patent expiry? What are the therapeutic and commercial trends to watch? How will national markets perform from 2010 to 2025? What will happen to the current leading products and drug classes? Our report covers those and other questions, providing the information that you need.

We predict that the global market for bone metabolism disorder drugs will expand from 2010 onwards, driven by increasing prevalence of disorders among a rising population of older people worldwide. National markets for those products will expand at different rates, as will different treatment forms. The market will depend upon products with superior performance for its success. Our new report shows how technologies that increase clinical effectiveness, safety and ease of use will be important therapeutically and commercially for bone disorders, benefiting stakeholders.

Detailed analysis of the global bone metabolism disorders market

Osteoporosis & Bone Metabolism Disorders: World Market 2010-2025 examines that sector through a comprehensive review of information sources. We harness both primary and secondary research. This report provides unique sales forecasts, market share analyses, discussions of the R&D pipeline and analyses of commercial drivers and restraints, including a SWOT analysis.

There are over 50 tables and figures included, as well as three full interviews with experts - these are totally unique and unavailable anywhere else. The result is a comprehensive market- and industry-centred study, with detailed analyses and informed opinion to benefit your work.

Why you should buy Osteoporosis & Bone Metabolism Disorders: World Market 2010-2025

This report gives you the following benefits in particular:
• You will receive a comprehensive analysis of the prospects for bone metabolism disorder drugs from 2010 to 2025, including predicted revenues, growth rates and other data for leading products
• You will receive an overall sales forecast for that market area from 2010 to 2025, as well as that for main drug classes, with comprehensive discussions and other supporting information
• You will find out where the market is heading - technologically and commercially - from 2010 onwards
• You will receive sales forecasts for the leading national markets from 2010 to 2025 (US, Japan, France, Germany, UK, Spain, Italy, Canada, China and India)
• You will identify R&D pipeline developments and up-and-coming products
• You will discover the drivers, restraints, competition and opportunities influencing the bone metabolism disorders treatment sector
• You will investigate under-met needs in that market sector, with therapeutic requirements and commercial opportunities discussed
• You will discover expert views from our survey, including full interview transcripts.